Completed NA INTERVENTIONAL 2-arm NCT01118208

Blister Packaging Medication to Increase Treatment Adherence and Clinical Response (BP)

Blister Packaging Medication to Increase Treatment Adherence and Clinical Response: Impact on Suicide-Related Morbidity and Mortality

Sponsor: United States Department of Defense

Conditions Accidental Overdose Deliberate Overdose Medication Adherence Suicide, Attempted

Interventions Blister packaging medications Dispense as usual

Updated 5 times since 2017 Last updated: Oct 18, 2017 Started: Sep 30, 2009 Primary completion: Jun 30, 2014 Completion: Sep 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Accidental Overdose and Deliberate Overdose and is currently completed. United States Department of Defense leads this study, which shows 5 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Sep 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

United States Department of Defense
VA Eastern Colorado Health Care System

Data source: VA Eastern Colorado Health Care System

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Denver, United States